European Cancer Patient Coalition

Tweet this page
<
2022
2023
>
Registration as it was on 21 Nov 2023
How to read and use this data card.
Download this datacard
The following entries are flagged as duplicates of this organisation: 57929627082-79

Overview

Lobbying Costs

100,000€ - 199,999€

Financial year: Jan 2022 - Dec 2022

Lobbyists (Full time equivalent)

3 Fte (9)

Lobbyists with EP accreditation

5

High-level Commission meetings

0

Lobbying Costs over the years

  • Info

    European Cancer Patient Coalition   (ECPC)

    EU Transparency Register

    782811248337-11 First registered on 08 Dec 2022

    Goals / Remit

    ECPC works for a Europe of equality, where all European cancer patients have timely and affordable access to the best treatment and care available. We work to ensure that the scope of the entire cancer care pathway effectively includes prevention, treatment, survivorship and palliative care.The main objectives of the years to come are to further support and advocate for cancer patient rights, to develop a strong engagement with the European Institutions members, to strengthen and make more frequent the connection with ECPC members, partners, and stakeholders during a period of many challenges in both the internal and external environment.

    Main EU files targeted

    ECPC participated in all stages of Europe's Beating Cancer Plan consultation and now actively contributes to the monitoring of the implementation process. ECPC also works on the Health Technology Assessment regulation and the In Vitro diagnostics regulation. The revision of the Pharmaceutical strategy is also among some of the most important priorities for ECPC. ECPC also participated in the consultations for cancer screening, Health Data space,EMA Data Standards Strategy consultation 2021, Directive of the Cross border care and the financial products for cancer survivors consultation

    Address

    Head Office
    Avenue des Arts 6
    Brussels 1210
    BELGIUM
    EU Office
    Avenue des Arts 6
    Brussels 1210
    BELGIUM

    Website

  • People

    Total lobbyists declared

    9

    Employment timeLobbyists
    100%1
    25%8

    Lobbyists (Full time equivalent)

    3

    Lobbyists with EP accreditation

    All Lobbyists with EP accreditation over time

    5 accreditations were / are live (in bold) for the selected state of 16 Apr 2024

    Name Start date End Date
    Michal KUBO 21 Apr 2023 19 Apr 2024
    Laura SAUCEDO CUEVAS 21 Sep 2023 13 Sep 2024
    Nicola DI FLORA 21 Apr 2023 19 Apr 2024
    Ane DE LAS HERAS MARTIN 12 May 2023 10 May 2024
    Lotan KRAUN 22 Sep 2023 20 Sep 2024
    Ms Lorena VARGAS TORTOSA 22 Sep 2023 12 Jan 2024
    Ms Laura SAUCEDO CUEVAS 21 Sep 2023 15 Apr 2024
    Ms Ane DE LAS HERAS MARTIN 12 May 2023 15 Apr 2024
    Mr Michal KUBO 21 Apr 2023 15 Apr 2024
    Mr Nicola DI FLORA 21 Apr 2023 15 Apr 2024
    Ms Malvika Vyas 13 Apr 2023 27 Apr 2023
    Ms Aliki STATHOPOULOU 14 Feb 2023 15 Feb 2024
    Ms Adela Maghear 18 Jan 2023 18 Jan 2024

    Complementary Information

    None declared

    Person in charge of EU relations

    Data not provided by Register Secretariat due to GDPR

    Person with legal responsibility

    Data not provided by Register Secretariat due to GDPR

  • Categories

    Category

    Non-governmental organisations, platforms and networks and similar

  • Networking

    Affiliation

    European Society for Medical Oncology (ESMO), European Medicines Agency, European Association of Urology, European, Alliance for Personalised Medicine,BBMRI-ERIC, Cancer Drug Development Forum, European Society of Surgical Oncology, European Academy of Cancer Sciences, EBMT, Cancer Core Europe, European Cancer Concord, Pancreatic Cancer Europe

    Member organisations

    None declared

  • Financial Data

    Interests represented

    Promotes their own interests or the collective interests of their members

    Closed financial year

    Jan 2022 - Dec 2022

    Lobbying costs for closed financial year

    100,000€ - 199,999€

    Major contributions in closed year

    None declared

    Major contributions in current year

    TypeNameAmount
    Grant CAN.HEAL 24,396€
    Grant PAL CYCLES 17,670€
    Grant CGI-CLINICS 113,713€
    Grant EOSC4CANCER 11,250€
    Grant UNCAN 140,415€
    Grant T2EVOLVE 27,657€
    Grant RELEVIUM 47,997€
    Grant MYPATH 37,187€
    Grant INSPIRE 61,381€
    Grant LEGACy 31,556€
    Grant AIDAVA 78,188€
    Grant TIGER 12,134€
    Grant PAINLESS 35,043€
    Grant PALL SEDATION 3,749€
    Grant INTERVENE 26,856€
    Grant INSTAND-NGS4P 43,962€
    Grant DIADIC 24,242€
    Grant IMMUNE-IMAGE 28,362€
    Grant QUALITOP 110,663€
    Grant IMMUNOSABR 17,227€
    Grant PIONEER 13,332€

    Intermediaries for closed year

    None declared

    Intermediaries for current year

    Name
    global cancer strategies

    Closed year Costs

    100,000€ - 199,999€

    Other financial info

    None declared

  • EU Structures

    Groups (European Commission)

    none

    Groups (European Parliament)

    Cancer

    Communication activities

    Each year we produce communication material (white papers, toolkits, booklets), conduct awareness campaigns in European level and organize live or online events aiming to inform the members of ECPC on the relevant EU policies on Cancer and support them at national level to increase their influence. ECPC also organizes an annual conference where all cancer patients around Europe participate and are informed on the latest policy developments around cancer.

    Other activities

    None declared

  • Meetings

    Meetings

    None declared

Download this datacard